MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Infectious Disease _ Pharmaceuticals, Biotechnology & Drugs
YishengBio
Attachments
YISHENG BIOPHARMA CO., LTD
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
*Architects: Infectious Disease _ Pharmaceuticals, Biotechnology & Drugs
Industry: China
Venture Capital: Series B
Children
2021: Co-led by Oceanpine and OrbiMed, the Series B included EightRoad, F-Prime Capital, 3W Capital, Hillhouse Capital, MSA Capital, AIHC, Epiphron Capital, Superstring Capital, Haitong International and Adjuvant Capital
2021: six-years-separated-from-a-rabies-vaccine-scandal-chinas-yishengbio-grabs-130m-to-go-big-in-infectious-diseases-cancer
Founded 1992